tiprankstipranks
Trending News
More News >
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Advertisement

ARS Pharmaceuticals (SPRY) Ratios

Compare
416 Followers

ARS Pharmaceuticals Ratios

SPRY's free cash flow for Q1 2025 was $0.00. For the 2025 fiscal year, SPRY's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
11.00 96.92 51.01 7.42 3.21
Quick Ratio
10.74 96.92 51.20 8.25 3.53
Cash Ratio
1.44 29.68 38.67 7.34 2.99
Solvency Ratio
-0.16 -22.36 -3.94 -0.22 0.02
Operating Cash Flow Ratio
-0.74 -24.79 -7.36 -2.14 1.10
Short-Term Operating Cash Flow Coverage
-280.60 0.00 -174.25 -5.05 3.55
Net Current Asset Value
$ 205.52M$ 229.30M$ 269.15M$ -31.98M$ -14.08M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 0.15 0.38
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 -0.29 -0.71
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 -0.41 -2.48
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 -0.19 -1.13
Financial Leverage Ratio
1.43 1.01 1.03 -1.97 -1.88
Debt Service Coverage Ratio
-374.49 0.00 -151.40 -5.30 -0.10
Interest Coverage Ratio
0.00 0.00 0.00 -183.53 -16.17
Debt to Market Cap
<0.01 0.00 <0.01 0.04 <0.01
Interest Debt Per Share
<0.01 <0.01 0.01 0.32 0.29
Net Debt to EBITDA
1.47 1.05 5.91 2.65 31.32
Profitability Margins
Gross Profit Margin
90.74%-143.33%-1216.11%-268.20%21.11%
EBIT Margin
10.41%-225066.67%-2698.78%-353.32%-2.63%
EBITDA Margin
-27.85%-224823.33%-2698.78%-349.46%-2.60%
Operating Profit Margin
-27.87%-225066.67%-2698.78%-353.32%-2.63%
Pretax Profit Margin
-15.82%-181216.67%-2635.41%-367.65%-5.97%
Net Profit Margin
-16.11%-181216.67%-2582.67%-367.65%-5.97%
Continuous Operations Profit Margin
18.83%-181216.67%-2635.41%-367.65%-5.97%
Net Income Per EBT
101.87%100.00%98.00%100.00%100.00%
EBT Per EBIT
56.75%80.52%97.65%104.06%227.08%
Return on Assets (ROA)
-4.78%-23.31%-12.08%-32.94%-4.03%
Return on Equity (ROE)
-6.94%-23.56%-12.46%64.74%7.58%
Return on Capital Employed (ROCE)
-9.03%-29.26%-12.87%-36.53%-2.58%
Return on Invested Capital (ROIC)
-9.20%-29.23%-12.59%-33.81%-1.83%
Return on Tangible Assets
-4.89%-23.38%-12.08%-32.94%-4.03%
Earnings Yield
-0.91%-10.42%-9.97%-10.53%-0.07%
Efficiency Ratios
Receivables Turnover
10.44 0.04 0.00 5.51K 46.45
Payables Turnover
0.00 0.10 10.44 11.35 11.54
Inventory Turnover
0.14 0.00 -17.17 -2.99 -5.39
Fixed Asset Turnover
84.67 0.04 1.70 7.95 775.43
Asset Turnover
0.30 <0.01 <0.01 0.09 0.68
Working Capital Turnover Ratio
0.33 <0.01 <0.01 0.16 3.31
Cash Conversion Cycle
2.70K 5.88K -56.23 -154.18 -91.47
Days of Sales Outstanding
34.96 9.67K 0.00 0.07 7.86
Days of Inventory Outstanding
2.67K 0.00 -21.26 -122.09 -67.71
Days of Payables Outstanding
0.00 3.79K 34.96 32.16 31.62
Operating Cycle
2.70K 9.67K -21.26 -122.02 -59.85
Cash Flow Ratios
Operating Cash Flow Per Share
-0.21 -0.62 -1.00 -0.61 0.26
Free Cash Flow Per Share
-0.21 -0.62 -1.01 -0.61 0.23
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 0.03
Free Cash Flow to Operating Cash Flow
1.03 1.00 1.00 1.00 0.90
Dividend Paid and CapEx Coverage Ratio
-35.87 -338.66 -201.40 -319.29 9.89
Capital Expenditure Coverage Ratio
-35.87 -338.66 -201.40 -319.29 9.89
Operating Cash Flow Coverage Ratio
-280.60 -216.30 -83.32 -1.94 0.91
Operating Cash Flow to Sales Ratio
-0.21 -1.98K -30.45 -3.19 0.51
Free Cash Flow Yield
-1.22%-11.39%-11.82%-9.16%0.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-109.08 -9.60 -10.03 -9.50 -1.51K
Price-to-Sales (P/S) Ratio
17.60 17.39K 258.99 34.92 90.16
Price-to-Book (P/B) Ratio
7.46 2.26 1.25 -6.15 -114.44
Price-to-Free Cash Flow (P/FCF) Ratio
-81.20 -8.78 -8.46 -10.92 197.21
Price-to-Operating Cash Flow Ratio
-83.34 -8.80 -8.50 -10.95 177.27
Price-to-Earnings Growth (PEG) Ratio
0.36 0.29 -0.47 >-0.01 15.77
Price-to-Fair Value
7.46 2.26 1.25 -6.15 -114.44
Enterprise Value Multiple
-61.74 -6.69 -3.68 -7.34 -3.44K
Enterprise Value
1.68B 451.08M 130.79M 141.26M 1.59B
EV to EBITDA
-62.29 -6.69 -3.68 -7.34 -3.44K
EV to Sales
17.35 15.04K 99.38 25.66 89.35
EV to Free Cash Flow
-80.02 -7.59 -3.25 -8.02 195.43
EV to Operating Cash Flow
-82.25 -7.61 -3.26 -8.04 175.68
Tangible Book Value Per Share
2.26 2.42 6.83 -1.08 -0.40
Shareholders’ Equity Per Share
2.34 2.42 6.83 -1.08 -0.40
Tax and Other Ratios
Effective Tax Rate
-0.02 0.00 0.02 0.01 0.19
Revenue Per Share
0.99 <0.01 0.03 0.19 0.51
Net Income Per Share
-0.16 -0.57 -0.85 -0.70 -0.03
Tax Burden
1.02 1.00 0.98 1.00 1.00
Interest Burden
-1.52 0.81 0.98 1.04 2.27
Research & Development to Revenue
0.18 675.53 13.96 3.68 0.79
SG&A to Revenue
0.66 1.58K 14.02 0.85 0.24
Stock-Based Compensation to Revenue
0.17 307.83 4.44 0.51 0.20
Income Quality
1.31 1.09 1.16 0.87 -8.52
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis